Clinical Trial Update: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating the safety and efficacy of Hectorol (doxercalciferol) for secondary hyperparathyroidism in children with chronic kidney disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)

Snippet

Sponsor: Sanofi | Conditions: Secondary Hyperparathyroidism-Chronic Kidney Disease | Phase 3 | Status: TERMINATED